Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:2LS'
s EV-to-EBIT Range Over the Past 10 Years
Min: -137.65 Med: 21.3 Max: 109.44
Current: 17.2
During the past 13 years, the highest EV-to-EBIT of PT Siloam International Hospitals Tbk was 109.44. The lowest was -137.65. And the median was 21.30.
FRA:2LS's EV-to-EBIT is ranked worse than 54.27% of 468
companies
in the Healthcare Providers & Services industry
Industry Median: 15.865
vs FRA:2LS: 17.20
PT Siloam International Hospitals Tbk (FRA:2LS) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
PT Siloam International Hospitals Tbk's Enterprise Value for the quarter that ended in Mar. 2026 was €1,786.8 Mil.
PT Siloam International Hospitals Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €88.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk EV-to-EBIT Related Terms
PT Siloam International Hospitals Tbk EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk EV-to-EBIT Chart
For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Siloam International Hospitals Tbk EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where PT Siloam International Hospitals Tbk's EV-to-EBIT falls into.
PT Siloam International Hospitals Tbk's current Enterprise Value is €1,430.8 Mil.
PT Siloam International Hospitals Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €88.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk (FRA:2LS) has a EV-to-EBIT of 16.24 as of Jul. 14, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PT Siloam International Hospitals Tbk and its competitors. This is 24% below median its historical median of 21.30. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #254 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 54.3%.
Is PT Siloam International Hospitals Tbk's EV-to-EBIT too high?
PT Siloam International Hospitals Tbk's current EV-to-EBIT of 16.24 is 24% below median its 10-year median of 21.30. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. PT Siloam International Hospitals Tbk's value of 16.24 is 2.4% above this industry median. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #254 out of 468 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #254 out of 468 companies for EV-to-EBIT. This places PT Siloam International Hospitals Tbk in the lower half of its industry. The industry median EV-to-EBIT is 15.87. PT Siloam International Hospitals Tbk's value of 16.24 is 2.4% above this benchmark. While the company's 10-year median is 21.30 vs. the industry median of 15.87, PT Siloam International Hospitals Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Siloam International Hospitals Tbk's current EV-to-EBIT of 16.24 is 2.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PT Siloam International Hospitals Tbk and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current EV-to-EBIT is 16.24, which is 24% below median its own 10-year median of 21.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
PT Siloam International Hospitals Tbk (FRA:2LS) has a current EV-to-EBIT of 16.24. The stock's GF Value™ is €0.12, compared to a current price of €0.10 — trading 18.3% below its estimated fair value. The current EV-to-EBIT is 16.24, which is 24% below median its 10-year median of 21.30 and 2.4% above the Healthcare Providers & Services industry median of 15.87. PT Siloam International Hospitals Tbk's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current EV-to-EBIT is 16.24 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.10 is trading 18.3% below its estimated GF Value™ of €0.12.
Key valuation signals for FRA:2LS:
EV-to-EBIT: 16.24 (24% below median its 10-year median of 21.30)
GF Value™: €0.12 vs. price of €0.10 (18.3% below fair value)
Industry Position: 2.4% above the Healthcare Providers & Services median (#254 of 468)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
94GF Score
Get the complete analysis for FRA:2LS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
